GlassScriptPhysician profile
David Marshall Jemison
NPI 1922075001
$7,490.56
in general payments reported to CMS, 2019-2025
19 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,434 · 2020: $392 · 2021: $1,318 · 2022: $1,398 · 2023: $185 · 2024: $439 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $3,419.13 | 2019-2022 | |
| Arthrex, INC. | $2,775.09 | 2019 | |
| Axogen | $247.71 | 2021-2025 | |
| Globus Medical, INC. | $191.49 | 2022-2024 | Nextgen Headless Screws, Distal Radius II |
| Abbott Laboratories | $173.71 | 2024 | Eterna |
| Polynovo North America LLC | $111.50 | 2022-2023 | |
| Lifenet Health | $95.85 | 2024 | Allograft Vmis Delivery System |
| Access Pro Medical, LLC | $80.12 | 2025 | Matriderm |
| Smoky Mountain Surgical LLC | $76.46 | 2023-2025 | |
| Medartis INC. | $70.19 | 2023 | Aptus |
| Integra Lifesciences Corporation | $68.83 | 2019 | |
| Aroa Biosurgery Incorporated | $33.76 | 2025 | |
| Teleflex LLC | $25.51 | 2025 | Quikclot |
| Linvatec Corporation | $25.11 | 2023 | Biobrace 23mm, Linvatec Extremities |
| Medtronic, INC. | $22.16 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $21.87 | 2025 | Exparel |
| Skeletal Dynamics INC | $18.68 | 2024 | Implate, Align, Ijs |
| Abbvie INC. | $16.87 | 2023 | |
| Endo Pharmaceuticals INC. | $16.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jemison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.